First-line antiemetics for nausea in palliative care and when to select a serotonin antagonist vs a dopamine antagonist?

Study for ELNEC 4: Symptom Management in Palliative Care Test with flashcards and multiple choice questions. Hints and explanations included! Get ready for your exam!

Matching the antiemetic to the cause of nausea is most effective in palliative care. Serotonin 5-HT3 antagonists are particularly helpful when nausea is driven by chemotherapy or by GI tract stimulation (such as visceral irritation or obstruction) because they block 5-HT3 receptors in the gut and the central vomiting center, quickly reducing emesis with a generally favorable safety profile. Dopamine antagonists are a good option for more general nausea—those not clearly linked to chemotherapy or GI triggers—because blocking D2 receptors in the chemoreceptor trigger zone and providing some prokinetic effects helps with a broader range of nausea symptoms. They do carry more risk of movement disorders and sedation, so they’re chosen when the nausea pattern fits their use and the patient can tolerate potential side effects. NK1 antagonists are effective, especially for chemotherapy-related nausea, but they’re not universally first-line for all types of nausea in palliative care. Antiemetics are indeed used to relieve symptoms, so saying they’re not used isn’t correct.